BpV(phen) trihydrate
Based on 3 publication(s) in Google Scholar
BpV(phen) trihydrate, a insulin-mimetic agent, is a potent protein tyrosine phosphatase (PTP) and PTEN inhibitor with IC50s of 38 nM, 343 nM and 920 nM for PTEN, PTP-β and PTP-1B, respectively. BpV(phen) trihydrate inhibits proliferation of the protozoan parasite Leishmania in vitro. bpV(phen) trihydrate strongly induces the secretion of a large number of chemokines and pro-inflammatory cytokines, and it activates a Th1-type pathway (IL-12, IFNγ). BpV(phen) trihydrate can also induce cell apoptosis, and has anti-angiogenic and anti-tumor activity.
For research use only. We do not sell to patients.
- Purity: 98.0%
- CAS No.: 171202-16-7
- Formula: C12H14KN2O8V
- Molecular Weight:404.29
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Anti-Infection Compound Library
HY-L002
-
Apoptosis Compound Library
HY-L003
-
Immunology/Inflammation Compound Library
HY-L007
-
Metabolism/Protease Compound Library
HY-L012
-
PI3K/Akt/mTOR Compound Library
HY-L015
-
Stem Cell Signaling Compound Library
HY-L017
-
Anti-Cancer Compound Library
HY-L025
-
Anti-Aging Compound Library
HY-L034
-
Oxygen Sensing Compound Library
HY-L045
-
Glycolysis Compound Library
HY-L058
-
Cytoskeleton Compound Library
HY-L060
-
Anti-Pancreatic Cancer Compound Library
HY-L077
-
Phosphatase Inhibitor Library
HY-L081
-
Antiparasitic Compound library
HY-L082
-
Anti-Cancer Metabolism Compound Library
HY-L083
-
Glucose Metabolism Compound Library
HY-L092
-
Antidepressant Compound Library
HY-L108
-
Pain-Related Compound Library
HY-L139
-
Metabolic Enzyme Compound Library
HY-L146
-
Cell Death Library
HY-L162
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
High-Throughput Bioactive Compound Library
HY-L205
Publications Citing Use of MedChemExpress (MCE) BpV(phen) trihydrate
MoreAll Parasite Isoforms
More
Biological Activity
|
Leishmania |
BpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment causes a further decrease of cell viability in H/R-injured H9c2 cells[1].
BpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment increases the apoptosis of H/R-injured H9c2 cells[1].
BpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment significantly promotes the accumulation of cytoplasmic Cytochrome C in H/R-injured H9c2 cells[1].
After stimulation of BpV(phen), PTEN-induced putative kinase protein 1 (PINK1)/Parkin-mediated mitophagy is inhibited[1].
BpV(phen) is an insulin-mimetic agent following insulin-receptor tyrosine kinase hyperphosphorylation and activation[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Hypoxia/reoxygenation (H/R)-injured H9c2 cells
-
Concentration:5 μM
-
Incubation Time:24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes)
-
Result:Caused a further decrease of cell viability.
-
Cell Line:Hypoxia/reoxygenation (H/R)-injured H9c2 cells
-
Concentration:5 μM
-
Incubation Time:24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes)
-
Result:Increased the apoptosis of H/R-injured H9c2 cells.
-
Cell Line:Hypoxia/reoxygenation (H/R)-injured H9c2 cells
-
Concentration:5 μM
-
Incubation Time:24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes)
-
Result:Showed an increased release of Cytochrome C.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male BALB/c nude (nu/nu) athymic mice (6-7 weeks old) injected with PC-3 cells[2]
-
Dosage:5 mg/kg
-
Administration:Intraperitoneal injection; daily; for 38 days
-
Result:Caused a significant reduction in average tumor volume.
Chemical Information
-
CAS No. 171202-16-7
-
Appearance Solid
-
Molecular Weight 404.29
-
Formula C12H14KN2O8V
-
Color Yellow to orange
-
SMILES
O=[V+3]12([N]3=CC=C4)([O-][O-]1)([O-][O-]2)[N]5=C6C3=C4C=CC6=CC=C5.O.O.O.[K+]
-
Synonyms
Bisperoxovanadium(phen) trihydrate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
The phosphatase PTEN links platelets with immune regulatory functions of mouse T follicular helper cells. [Abstract]2022 May 19;13(1):2762. PMID: 35589797 -
Biochem Bioph Res Co
2020 Sep 3;529(4):1045-1052. PMID: 32819563 -
Am J Mens Health
The Guangsi Yulin Decoction Inhibits Oxidative Stress and Inflammation-Induced Spermatogenesis Dysfunction via the PTEN/ PI3K/ AKT/ FoxO1 Pathway. [Abstract]2026 Mar-Apr;20(2):15579883261427164. PMID: 41807111
Solvent & Solubility
H2O : 100 mg/mL (247.35 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 25 mg/mL (61.84 mM); Clear solution; Need ultrasonic and warming
Purity & Documentation
-
Data Sheet (298 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Tang W, et al. PTEN-mediated mitophagy and APE1 overexpression protects against cardiac hypoxia/reoxygenation injury. In Vitro Cell Dev Biol Anim. 2019 Oct;55(9):741-748. [Content Brief]
[2]. Caron D, et al. Protein tyrosine phosphatase inhibition induces anti-tumor activity: evidence of Cdk2/p27 kip1 and Cdk2/SHP-1 complex formation in human ovarian cancer cells. Cancer Lett. 2008 Apr 18;262(2):265-75. [Content Brief]
[3]. Schmid AC, et al. Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett. 2004 May 21;566(1-3):35-8. [Content Brief]
[4]. Band CJ, et al. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen). Mol Endocrinol. 1997 Dec;11(13):1899-910. [Content Brief]
[5]. Chen Q, et al. Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (bpV(phen)) Induces Apoptosis and Pyroptosis and Disrupts the P62-HDAC6 Protein Interaction to Suppress the Acetylated Microtubule-dependent Degradation of Autophagosomes. J Biol Chem. 2015 Oct 23;290(43):26051-8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 2.4735 mL | 12.3674 mL | 24.7347 mL | 61.8368 mL |
| 5 mM | 0.4947 mL | 2.4735 mL | 4.9469 mL | 12.3674 mL | |
| 10 mM | 0.2473 mL | 1.2367 mL | 2.4735 mL | 6.1837 mL | |
| 15 mM | 0.1649 mL | 0.8245 mL | 1.6490 mL | 4.1225 mL | |
| 20 mM | 0.1237 mL | 0.6184 mL | 1.2367 mL | 3.0918 mL | |
| 25 mM | 0.0989 mL | 0.4947 mL | 0.9894 mL | 2.4735 mL | |
| 30 mM | 0.0824 mL | 0.4122 mL | 0.8245 mL | 2.0612 mL | |
| 40 mM | 0.0618 mL | 0.3092 mL | 0.6184 mL | 1.5459 mL | |
| 50 mM | 0.0495 mL | 0.2473 mL | 0.4947 mL | 1.2367 mL | |
| 60 mM | 0.0412 mL | 0.2061 mL | 0.4122 mL | 1.0306 mL | |
| 80 mM | 0.0309 mL | 0.1546 mL | 0.3092 mL | 0.7730 mL | |
| 100 mM | 0.0247 mL | 0.1237 mL | 0.2473 mL | 0.6184 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
BpV(phen) trihydrate Related Classifications
HY-122818 Related Classifications
Powered by Bioz
- BpV(phen)
- 171202-16-7
- Bisperoxovanadium(phen)
- PTEN
- Phosphatase
- Parasite
- Apoptosis
- PTP
- Cytochrome C
- mitochondria
- hypoxia
- reoxygenation
- PINK1
- Peroxovanadiums
- anti-tumor
- anti-proliferative Hypoxia/reoxygenation (H/R)-injured H9c2 cells[1] 5 μM 24.5 hours (hypoxia for 24 h
- reoxygenation for 30 minutes) Increased the apoptosis of H/R-injured H9c2 cells. Hypoxia/reoxygenation (H/R)-injured H9c2 cells[1] 5 μM 24.5 hours (hypoxia for 24 h
- reoxygenation for 30 minutes) Showed an increased release of Cytochrome C.
- Inhibitor
- inhibitor
- inhibit